The latest update is out from Sanofi India Limited ( (IN:SANOFI) ).
Sanofi India Limited announced the approval of its standalone and consolidated financial results for the quarter and year ended December 31, 2024, by the Board of Directors. The results, audited by Price Waterhouse & Co. with an unmodified opinion, will be published in newspapers and available on the company’s website. Additionally, the Board recommended a final dividend of ₹117 per equity share, pending shareholder approval at the upcoming Annual General Meeting, reflecting the company’s robust financial performance and commitment to shareholder returns.
More about Sanofi India Limited
Sanofi India Limited operates in the pharmaceutical industry, focusing on the development and distribution of healthcare solutions. The company is known for its wide range of pharmaceutical products and services, catering to various healthcare needs in the Indian market.
YTD Price Performance: -16.98%
Average Trading Volume: 1,117
Current Market Cap: 116.5B INR
See more insights into SANOFI stock on TipRanks’ Stock Analysis page.